Shareholders' equity (Tables)
|
3 Months Ended |
Mar. 31, 2021 |
| Shareholders’ equity |
|
| Schedule of additional paid-in capital |
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31,
|
|
|
|
|
2021
|
|
2020
|
|
|
Opening balance
|
|
$
|
8,530
|
|
$
|
3,805
|
|
|
Share-based compensation expense
|
|
|
1,368
|
|
|
981
|
|
|
Exercise of stock options
|
|
|
(15)
|
|
|
(56)
|
|
|
Closing balance
|
|
$
|
9,883
|
|
$
|
4,730
|
|
|
| Schedule of outstanding and exercisable options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
Number
|
|
|
|
average
|
|
|
Number
|
|
|
|
average
|
|
|
|
|
of shares
|
|
|
|
exercise
|
|
|
of shares
|
|
|
|
exercise
|
|
|
|
|
2019 Plan
|
|
|
2011 Plan
|
|
Total
|
|
price
|
|
|
2019 Plan
|
|
|
2011 Plan
|
|
Total
|
|
price
|
|
Outstanding at beginning of year - 2011 Plan
|
|
|
—
|
|
|
2,080,087
|
|
2,080,087
|
|
$
|
2.15
|
|
|
—
|
|
|
2,364,526
|
|
2,364,526
|
|
$
|
2.15
|
|
Outstanding at beginning of year - 2019 Plan
|
|
|
1,706,190
|
|
|
—
|
|
1,706,190
|
|
|
13.55
|
|
|
220,140
|
|
|
—
|
|
220,140
|
|
|
20.78
|
|
Granted - 2019 Plan
|
|
|
1,863,950
|
|
|
—
|
|
1,863,950
|
|
|
6.31
|
|
|
765,160
|
|
|
—
|
|
765,160
|
|
|
21.49
|
|
Exercised - 2011 Plan
|
|
|
—
|
|
|
(16,753)
|
|
(16,753)
|
|
|
0.88
|
|
|
—
|
|
|
(53,722)
|
|
(53,722)
|
|
|
1.44
|
|
Exercised - 2019 Plan
|
|
|
(1,250)
|
|
|
—
|
|
(1,250)
|
|
|
3.74
|
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
Forfeited - 2011 Plan
|
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,978)
|
|
(4,978)
|
|
|
2.12
|
|
Forfeited - 2019 Plan
|
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
(2,750)
|
|
|
—
|
|
(2,750)
|
|
|
21.48
|
|
Outstanding at end of period
|
|
|
3,568,890
|
|
|
2,063,334
|
|
5,632,224
|
|
$
|
6.99
|
|
|
982,550
|
|
|
2,305,826
|
|
3,288,376
|
|
$
|
7.89
|
|
Outstanding at end of period - Weighted average exercise price
|
|
$
|
9.77
|
|
$
|
2.16
|
|
|
|
|
|
|
$
|
21.33
|
|
$
|
2.17
|
|
|
|
|
|
|
Exercisable at end of period
|
|
|
591,885
|
|
|
1,613,229
|
|
2,205,114
|
|
$
|
4.86
|
|
|
5,660
|
|
|
1,327,637
|
|
1,333,297
|
|
$
|
1.92
|
|
Exercisable at end of period - Weighted average exercise price
|
|
$
|
12.55
|
|
$
|
2.05
|
|
|
|
|
|
|
$
|
18.43
|
$
|
|
1.85
|
|
|
|
|
|
|
| Schedule of non-vested share options activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
|
|
Number
|
|
|
|
Weighted
|
|
|
Number
|
|
|
|
Weighted
|
|
|
|
of options
|
|
|
|
average
|
|
|
of options
|
|
|
|
average
|
|
|
|
2019 Plan
|
|
2011 Plan
|
|
Total
|
|
fair value
|
|
|
2019 Plan
|
|
2011 Plan
|
|
Total
|
|
fair value
|
|
Non-vested share options at beginning of year - 2011 Plan
|
|
—
|
|
543,192
|
|
543,192
|
|
$
|
1.81
|
|
|
—
|
|
1,152,300
|
|
1,152,300
|
|
$
|
1.88
|
|
Non-vested share options at beginning of year - 2019 Plan
|
|
1,438,026
|
|
—
|
|
1,438,026
|
|
$
|
10.28
|
|
|
218,975
|
|
—
|
|
218,975
|
|
$
|
14
|
|
Granted - 2019 Plan
|
|
1,863,950
|
|
—
|
|
1,863,950
|
|
|
4.79
|
|
|
765,160
|
|
—
|
|
765,160
|
|
|
15.19
|
|
Vested, outstanding 2011 Plan
|
|
—
|
|
(93,087)
|
|
(93,087)
|
|
|
1.61
|
|
|
—
|
|
(169,133)
|
|
(169,133)
|
|
|
5.81
|
|
Vested, outstanding 2019 Plan
|
|
(324,971)
|
|
—
|
|
(324,971)
|
|
|
11.38
|
|
|
(4,495)
|
|
—
|
|
(4,495)
|
|
|
12.85
|
|
Forfeited - 2011 Plan
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
(4,978)
|
|
(4,978)
|
|
|
1.52
|
|
Forfeited - 2019 Plan
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
(2,750)
|
|
—
|
|
(2,750)
|
|
|
15.25
|
|
Non-vested share options at end of period
|
|
2,977,005
|
|
450,105
|
|
3,427,110
|
|
$
|
6.08
|
|
|
976,890
|
|
978,189
|
|
1,955,079
|
|
$
|
8.12
|
|
Non-vested share options at end of period - Weighted average fair value
|
$
|
6.72
|
$
|
1.85
|
|
|
|
|
|
|
$
|
11.80
|
$
|
1.21
|
|
|
|
|
|
|
| Schedule of weighted average assumptions for the options granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
|
Exercise price
|
$
|
6.31
|
|
$
|
21.41
|
|
|
Share price
|
$
|
6.31
|
|
$
|
21.41
|
|
|
Volatility
|
|
94
|
%
|
|
82
|
%
|
|
Risk-free interest rate
|
|
1.06
|
%
|
|
1.60
|
%
|
|
Expected life
|
|
6.10 years
|
|
|
6.24 years
|
|
|
Dividend
|
|
0
|
%
|
|
0
|
%
|
|
| Schedule of share-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021
|
|
2020
|
|
|
Administration
|
|
$
|
573
|
|
$
|
399
|
|
|
Research and development
|
|
|
580
|
|
|
386
|
|
|
Commercial activities
|
|
|
215
|
|
|
196
|
|
|
|
|
$
|
1,368
|
|
$
|
981
|
|
|